December 2016

Editor's Page
Where Do Clinical Pathways Go From Here?
Winston Wong, PharmD, Editor-in-Chief

J Clin Pathways. 2016;2(10):5.

Departments

Editor's Page
Where Do Clinical Pathways Go From Here?
Winston Wong, PharmD, Editor-in-Chief

J Clin Pathways. 2016;2(10):5.

Research in Review
Few RCTs of New Systemic Therapies Met ESMO Guidelines for Meaningful Outcomes
JCP Editors

J Clinical Pathways. 2016;2(10):6-10.

Research in Review
High-Intensity End-of-Life Care Common Among Pediatric Cancer Patients
JCP Editors

J Clin Pathways. 2016;2(10):6-10.

Interview
Improving Access to Quality Cancer Care Close to Home
JCP Editors

J Clin Pathways. 2017;2(10):27-28.

Research in Review
Insurance Expansion Improves Resection Rates Among Patients with Colorectal Cancer
JCP Editors
Conference Coverage
58th American Society of Hematology (ASH) Annual Meeting & Exposition
JCP Editors
Research in Review
Specialized Surveillance Cost-Effective, Not Linked to Overtreatment in High-Risk Melanoma Population
JCP Editors

J Clin Pathways. 2016;2(10):6-10.

Research in Review
Steep Increases in Genetic Test Cancellations Seen Following Mandated Genetic Counseling
JCP Editors

J Clin Pathways. 2016;2(10):6-10.

Research in Review
Hormone Receptor-Negative Breast Cancers Gain Greatest Economic Benefit from Trastuzumab
JCP Editors

J Clin Pathways. 2016;2(10):6-10.

Features

Viewpoint
Rethinking Health Care Delivery
Ned L Woody

J Clin Pathways. 2016;2(10):39-42.

Back to Top